TESARIL DM SR DUO Tablets – Dapagliflozin 10 mg + Sitagliptin 100 mg + Metformin 1000 mg
TESARIL DM SR DUO Tablets – Dapagliflozin, Sitagliptin and Metformin Hydrochloride tablets features Sitagliptin, a DPP-4 inhibitor that enhances incretin hormones to improve glycemic control, alongside Dapagliflozin, an SGLT2 inhibitor that facilitates glucose elimination through urine, and Metformin, which lowers blood sugar levels by decreasing liver glucose production and improving insulin action. Together, they offer a multifaceted approach to managing type-2 diabetes, effectively addressing various mechanisms involved in glucose regulation.
Recommended by specialists:
✅ Diabetologist: For diagnosing and treating diabetes mellitus.
✅ General Physician: For management of type 2 diabetes.
Key benefits of Sitagliptin 100mg + Dapagliflozin 10mg + Metformin 1000mg (SR) Tablets -TESARIL DM SR DUO Tablets :
✅ Synergistic Mechanism of Action : Combines the DPP-4 inhibition of Sitagliptin, which increases incretin levels to boost insulin secretion and lower glucagon levels, with Dapagliflozin’s SGLT2 inhibition that promotes renal glucose excretion and Metformin’s ability to enhance insulin sensitivity and reduce hepatic glucose production.
✅ Holistic Glycemic Management: Effectively targets both fasting and postprandial glucose levels, providing a robust solution for comprehensive diabetes control.
✅ Convenient Single Tablet Dosing: This combination allows for once-daily dosing, simplifying the treatment regimen and improving patient adherence to therapy.
✅ Sustained Release Formulation: Ensures a steady release over time, and improves patient compliance.
Indications
✅ Type 2 Diabetes Mellitus
✅ Inadequate glycemic control
✅ Monotherapy resistance